OpenEvidence, which Forbes profiled in July, has been signing up users fast. Its ultimate goal: To not just help doctors find existing medical research, but to create medical superintelligence.
ByAmy Feldman,
Forbes Staff
andRashi Shrivastava,
Forbes Staff.
O
Daniel Nadler, the 42-year-old CEO and cofounder of OpenEvidence, is now worth $7.6 billion as his AI search tool surges in…
OpenEvidence, based in Massachusetts, has topped a $12 billion valuation in a funding round led by Thrive and DST.
OpenAI’s Sam Altman didn’t build his fortune off his modest CEO salary. The tech titan’s $1.9 billion net worth is thanks to…
The rapid rise of AI startups OpenAI, Anthropic and xAI has spurred a historic increase in private market valuations.
Today’s Forbes Daily newsletter covers Amazon’s latest AI investment, Novo Nordisk’s tough Ozempic test, SoftBank stumbles,…
After OpenAI raised the largest private tech financing round on record last year at over $40 billion, Anthropic is now second,…
